Silvervine Limited
Unaudited Financial Statements
For the year ended 31 March 2023
Pages for Filing with Registrar
Company Registration No. 02092045 (England and Wales)
Silvervine Limited
Company Information
Directors
Dr P Myers
Dr V Anand
Dr I Lezcano Ibanez
Dr N Leigh-Collyer
Secretary
Dr P Myers
Company number
02092045
Registered office
The Surgery
99 Western Road
Romford
Essex
RM1 3LS
Accountants
Moore Kingston Smith LLP
Orbital House
20 Eastern Road
Romford
Essex
RM1 3PJ
Silvervine Limited
Contents
Page
Balance sheet
1
Notes to the financial statements
2 - 3
Silvervine Limited
Balance Sheet
As at 31 March 2023
Page 1
2023
2022
Notes
£
£
£
£
Current assets
Debtors
3
515
-
0
Cash at bank and in hand
1,481
1,810
1,996
1,810
Creditors: amounts falling due within one year
4
(1,992)
(1,806)
Net current assets
4
4
Capital and reserves
-
-
Called up share capital
5
4
4

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 March 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 9 October 2023 and are signed on its behalf by:
Dr N Leigh-Collyer
Director
Company Registration No. 02092045
Silvervine Limited
Notes to the Financial Statements
For the year ended 31 March 2023
Page 2
1
Accounting policies
Company information

Silvervine Limited is a private company limited by shares incorporated in England and Wales. The registered office and business address is The Surgery, 99 Western Road, Romford, Essex, RM1 3LS.

1.1
Accounting convention

These financial statements have been prepared in accordance with Section 1A of FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Going concern

At the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for thetrue foreseeable future and for a period of at least twelve months following the approval of these financial statements. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3
Turnover
Turnover represents amounts receivable from the occupiers of the managed property.
1.4
Cash and cash equivalents

Cash at bank and in hand are basic financial assets and include cash in hand and deposits held at call with banks.

1.5
Financial instruments

All of the company's financial assets and liabilities are basic and measured at amortised cost.

1.6
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was 0 (2022: 0).

3
Debtors
2023
2022
Amounts falling due within one year:
£
£
Trade debtors
515
-
0
Silvervine Limited
Notes to the Financial Statements (Continued)
For the year ended 31 March 2023
Page 3
4
Creditors: amounts falling due within one year
2023
2022
£
£
Trade creditors
-
0
114
Other creditors
992
992
Accruals and deferred income
1,000
700
1,992
1,806
5
Called up share capital
2023
2022
2023
2022
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary shares of £1 each
4
4
4
4
2023-03-312022-04-01false10 October 2023CCH SoftwareCCH Accounts Production 2023.200No description of principal activityDr P MyersDr V AnandDr I Lezcano IbanezDr N Leigh-CollyerDr N Leigh-CollyerDr P Myers020920452022-04-012023-03-3102092045bus:CompanySecretaryDirector12022-04-012023-03-3102092045bus:Director22022-04-012023-03-3102092045bus:Director32022-04-012023-03-3102092045bus:Director42022-04-012023-03-3102092045bus:CompanySecretary12022-04-012023-03-3102092045bus:Director12022-04-012023-03-3102092045bus:Director52022-04-012023-03-3102092045bus:RegisteredOffice2022-04-012023-03-31020920452023-03-31020920452022-03-3102092045core:CurrentFinancialInstrumentscore:WithinOneYear2023-03-3102092045core:CurrentFinancialInstrumentscore:WithinOneYear2022-03-3102092045core:ShareCapital2023-03-3102092045core:ShareCapital2022-03-3102092045core:CurrentFinancialInstruments2023-03-3102092045core:CurrentFinancialInstruments2022-03-3102092045bus:PrivateLimitedCompanyLtd2022-04-012023-03-3102092045bus:SmallCompaniesRegimeForAccounts2022-04-012023-03-3102092045bus:FRS1022022-04-012023-03-3102092045bus:AuditExemptWithAccountantsReport2022-04-012023-03-3102092045bus:FullAccounts2022-04-012023-03-31xbrli:purexbrli:sharesiso4217:GBP